Seeking Alpha

Managing

Managing
Send Message
View as an RSS Feed
View Managing's Comments BY TICKER:
Latest  |  Highest rated
  • GE Getting Leaner And Less Levered [View article]
    For years GE Capital rolled up an entire leasing industry while the Feds did nothing about anti-trust and now we come full circle and those same blokes are on the chopping block for their own jobs. GE Capital crushed a vibrant industry in equipment leasing and now we have a diaspora of assets and talent. Seems to me that the opportunities await the buyers not the seller. Don't know what they plan with all that cash
    Jun 9, 2015. 08:31 PM | Likes Like |Link to Comment
  • Roen Ventures Wins Summary Judgment In Its Lawsuit Against Medical Marijuana, Inc [View article]
    The main point is the judge found that MJNA management are dead beats which they didn't disclose to the shareholders.
    Apr 3, 2015. 10:10 AM | Likes Like |Link to Comment
  • Orexigen - Contrave Scripts Rise Over 6%, But The Focus Is On Europe [View article]
    approval received. Now we will see how much of this anticipated event was built into the share price compared to the need of the shorts to cover.
    Mar 26, 2015. 05:51 PM | Likes Like |Link to Comment
  • Orexigen's obesity drug cleared in Europe [View news story]
    I am sure the shorts will see this as nothing but a potential disaster for the stock.
    Mar 26, 2015. 05:49 PM | 3 Likes Like |Link to Comment
  • Orexigen - Contrave Scripts Rise Over 6%, But The Focus Is On Europe [View article]
    Krap_buster should cover his short.
    Mar 16, 2015. 12:33 PM | 1 Like Like |Link to Comment
  • Orexigen's Contrave Blunder Due To Weak Intellectual Property Position [View article]
    No Jim I have more. Your comments and language is clearly reckless and irresponsible. Clearly you are biased and motivated to beat down the the stock with unsubstantiated opinions.
    Mar 10, 2015. 10:20 AM | 1 Like Like |Link to Comment
  • Orexigen's Contrave Blunder Due To Weak Intellectual Property Position [View article]
    Jim you never answered the 1st question: How's your shares of Arena doing these days?
    Mar 9, 2015. 02:56 PM | 1 Like Like |Link to Comment
  • Orexigen's Contrave Blunder Due To Weak Intellectual Property Position [View article]
    Jim Roof never answered the first question: How is your Arena investment doing?
    Mar 9, 2015. 02:54 PM | 2 Likes Like |Link to Comment
  • The Latest FDA Contrave Rhetoric Is A Departure From Reality [View article]
    "There are other choices less harmful and just as effective including adding phentermine to Belviq that are safer. Doctors are obligated to choose the safer choice."

    If the heart benefits are well understood and widely available then why isn't someone else doing this?
    Mar 6, 2015. 01:54 PM | 5 Likes Like |Link to Comment
  • Orexigen Soars: Good News Is Heart Data, Bad News Is Data May Be Compromised [View article]
    In the worst case scenario the author is long Arena.
    Mar 4, 2015. 10:45 AM | 1 Like Like |Link to Comment
  • How Will Marijuana Stocks React To Election Results In Alaska And Oregon? [View article]
    trabob,

    It doesn't. Blind faith does. WA DC went legal along with AK. The tide is coming in.
    Mar 3, 2015. 04:24 PM | Likes Like |Link to Comment
  • Orexigen's Contrave data release may have not have been a good idea [View news story]
    Good points all, but the release cleaned out the shorts (for the time being). Hard to argue a 50% pop
    Mar 3, 2015. 04:18 PM | Likes Like |Link to Comment
  • Orexigen: Contrave Scripts Dip With Sector [View article]
    Doesn't this micro analysis of weekly sales miss the bigger picture? Size matters OREX has the biggest sales force and market potential with positive signs coming out of the EU. Glad I hung in there outlasting the shorts and the Arena fans talking their own book.
    Mar 3, 2015. 11:26 AM | 1 Like Like |Link to Comment
  • Immuno-Oncology Is The Future Of Cancer Treatment: My Money Is On Juno Therapeutics [View article]
    For a sector potentially this broad, I wouldn't expect a zero sum game. But the breakout leader will be the one that (hopefully) successfully applies the technology to solid tumors.
    Mar 2, 2015. 02:31 PM | 1 Like Like |Link to Comment
  • Orexigen's Earnings Report Gives Clarity On Future Revenues [View article]
    At the end of the day size matters. The sales force that OREXIGEN has at its disposal should eventually gain the upper hand.
    Mar 2, 2015. 01:55 PM | 1 Like Like |Link to Comment
COMMENTS STATS
297 Comments
319 Likes